塞法胺是一种潜在的药物,通过增加细胞p27的细胞增殖来抑制细胞增殖
Tingting Zhang1,2, Caixia Qiao1, Yunshan Yang1,3
1Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu Province, 215123, China.
The Journal of antibiotics
|June 19, 2024
概括
抗生素ceftazidime通过调高p27蛋白和调低Skp2.2来抑制癌细胞的增殖. 这一发现提供了潜在的新的抗瘤治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 类抗生素,像ceftazidime一样,广泛用于对抗细菌感染.
- 重新利用现有药物为各种疾病提供治疗优势.
- 蛋白质p27调节细胞循环,其失调与癌症有关.
研究的目的:
- 为了研究ceftazidime的非抗菌作用.
- 为了探索ceftazidime在调节细胞增殖中的机制.
- 评估塞夫塔齐迪姆作为抗癌疗法的潜力.
主要方法:
- 评估塞夫塔齐迪姆对p27蛋白水平和无处不在的作用.
- 分析塞夫塔齐对细胞周期进展 (G1到S阶段) 的影响.
- 调查Skp2 (SCF泛基因酶成分) 在赛夫塔齐的作用中的作用.
- 评估ceftazidime在抑制瘤细胞增殖中的有效性.
主要成果:
- 塞法胺通过抑制其无处不在的化,显著上调p27蛋白水平.
- 塞法胺阻碍了细胞周期从G1到S阶段的进展,抑制了增殖.
- 塞法胺降低了Skp2水平,这是p27降解的关键因素.
- 塞夫塔胺在体内显示出瘤细胞增殖的抑制.
结论:
- 塞法胺通过Skp2-p27信号轴抑制细胞增殖.
- 这种机制揭示了ceftazidime的新型抗瘤潜力.
- 塞法胺是开发新抗癌疗法的有希望的候选人.
更多相关视频
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Molecular Factors Affecting Cell Division
3.0K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.0K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


